Current Research

 

The FORTITUDE Trial - A 2x2 Factorial, Randomized, Open-label Trial to Evaluate Neuromodulators and Cough Control Therapy in Patients With Refractory or Unexplained Chronic Cough

 

CanMUC - Canadian Consortium on Airway Mucus Occlusions in Asthma, COPD and Chronic Cough

 

Trevi Therapeutics - A Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study to Evaluate the Efficacy and Safety of Nalbuphine Extended-Release Tablets for the Treatment of ParticipantsWith Refractory Chronic Cough (LAKE)